Best Psychiatry Journals (2026): Ranked by Impact and Accessibility
A ranked guide to the top 13 psychiatry journals by impact factor, acceptance rate, APC, and review time, from JAMA Psychiatry and Lancet Psychiatry to accessible open-access options.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Psychiatry is one of the broadest fields in medicine when it comes to journal options. The discipline spans clinical trials of psychotropic medications, neuroimaging studies, psychotherapy outcomes, epidemiological surveys, qualitative research, and everything between. This breadth means the journal landscape is fragmented in a way that other specialties aren't. A biological psychiatry paper and a qualitative study of patient experiences belong in completely different journals, even though both are "psychiatry."
The field also sits at an interesting intersection. High-impact general medical journals like NEJM and Lancet regularly publish psychiatry research, which means the top psychiatry specialty journals compete not just with each other but with generalist titles. Understanding this competitive landscape is essential for choosing where to submit.
Quick Answer: Top 5 Psychiatry Journals
- Lancet Psychiatry (IF ~24.8) for high-impact clinical research
- JAMA Psychiatry (IF ~17.1) for evidence-based clinical psychiatry
- Biological Psychiatry (IF ~9.0) for neuroscience-oriented research
- Molecular Psychiatry (IF ~11.0) for molecular and genetic mechanisms
- American Journal of Psychiatry (IF ~16.3) for clinical psychiatry research
Full Comparison Table
Journal | IF | Acceptance Rate | APC | Review Time | Scope |
|---|---|---|---|---|---|
Lancet Psychiatry | ~24.8 | ~5% | $5,690 (OA) | 4-6 weeks | Clinical, high impact |
JAMA Psychiatry | ~17.1 | ~5% | Subscription | 4-8 weeks | Clinical, evidence-based |
American Journal of Psychiatry | 14.7 | ~7% | $3,500 (OA option) | 6-10 weeks | Clinical psychiatry |
Biological Psychiatry | ~9.0 | ~10% | $4,000 (OA option) | 6-10 weeks | Neuroscience, imaging |
Molecular Psychiatry | ~11.0 | ~12% | $5,590 (OA option) | 6-12 weeks | Molecular mechanisms |
Translational Psychiatry | ~6.8 | ~25% | $4,290 (OA) | 4-8 weeks | Translational, open access |
Psychological Medicine | ~6.4 | ~15% | $3,600 (OA option) | 6-10 weeks | Clinical, epidemiological |
British Journal of Psychiatry | ~8.7 | ~12% | $3,400 (OA option) | 6-10 weeks | Clinical, UK-based |
Schizophrenia Bulletin | 4.8 | ~18% | $3,200 (OA option) | 6-10 weeks | Schizophrenia research |
Journal of Clinical Psychiatry | ~5.2 | ~15% | Subscription | 8-12 weeks | Clinical practice |
BJPsych Open | ~4.0 | ~30% | $2,400 (OA) | 4-6 weeks | Open access, broad |
Frontiers in Psychiatry | ~3.2 | ~40% | $2,950 (OA) | 8-14 weeks | Open access, broad |
Acta Psychiatrica Scandinavica | ~5.8 | ~18% | $3,200 (OA option) | 6-10 weeks | Clinical, Scandinavian |
Elite Tier: Extremely Competitive
Lancet Psychiatry
This journal has rapidly become the most impactful title in psychiatry. It publishes major clinical trials, large epidemiological studies, and policy-relevant research. The Lancet brand ensures that papers here reach policymakers, media, and general medical audiences. If your work has implications for clinical guidelines or health policy, Lancet Psychiatry is the dream target. But be realistic. The acceptance rate is around 5%.
JAMA Psychiatry
JAMA Psychiatry is exceptionally selective and values methodological rigor above all else. It publishes clinical trials, meta-analyses, and large observational studies. The JAMA network amplifies visibility across medicine, and the structured review process provides useful feedback even on rejected manuscripts. This journal is particularly strong for population-based studies and health services research.
American Journal of Psychiatry (AJP)
AJP is the APA's flagship and arguably the most prestigious US psychiatry journal for original clinical research. It covers clinical trials, neuroimaging, and translational psychiatry. AJP has a slightly broader scope than JAMA Psychiatry, accepting some biological and translational work alongside clinical studies. The review process is thorough and the editorial standards are high.
Biological Psychiatry
This is the leading journal for neuroscience-oriented psychiatry research. If your paper involves neuroimaging, genetics, pharmacology, or circuit-level neuroscience applied to psychiatric disorders, Biological Psychiatry is the appropriate elite target. It doesn't publish clinical trials in the traditional sense. Rather, it wants mechanistic insights into mental illness. The SOBP society backing gives it a strong conference connection.
Strong Tier: Respected and Achievable
Molecular Psychiatry
Part of the Nature Publishing Group, Molecular Psychiatry focuses on the molecular and genetic underpinnings of psychiatric disorders. It's competitive but slightly more accessible than Biological Psychiatry for certain types of work, particularly genetic association studies and molecular biomarker research. The review process can be slow, so factor that into your timeline.
British Journal of Psychiatry (BJPsych)
BJPsych is the RCPsych's flagship and carries significant weight in UK and European psychiatry. It publishes clinical research, systematic reviews, and health services research with a strong emphasis on public mental health. If your work has relevance to UK or European healthcare systems, BJPsych is a natural fit.
Psychological Medicine
This Cambridge-published journal bridges psychiatry and psychology, publishing epidemiological studies, clinical trials, and psychological research. It's a strong venue for studies that don't fit neatly into biological or purely clinical categories. If your research involves psychological mechanisms, risk factors, or population mental health, Psychological Medicine is worth considering.
Schizophrenia Bulletin
The leading specialty journal for schizophrenia and psychosis research. It publishes clinical, biological, and psychological research focused on psychotic disorders. If your study population involves patients with schizophrenia or related conditions, this focused journal offers expert reviewers and an engaged readership that generalist titles can't match.
Acta Psychiatrica Scandinavica
A well-respected European journal with consistently strong clinical research. It's particularly good for epidemiological studies, treatment outcome research, and register-based studies. Scandinavian register studies are a staple, but the journal accepts international submissions readily.
Translational Psychiatry
Nature's open access journal for translational psychiatry research has carved out a strong niche. It bridges basic neuroscience and clinical psychiatry, and the OA model ensures broad readership. For researchers who want Nature group prestige with a more accessible acceptance rate, this is a compelling option.
Accessible Tier: Broader Options
BJPsych Open
The open access companion to BJPsych has grown steadily. It publishes well-designed clinical and health services research that may not reach the novelty threshold of the parent journal. The APC is moderate, and the review process is constructive. A good option for early-career researchers.
Frontiers in Psychiatry
Frontiers in Psychiatry has a high acceptance rate and publishes across the full breadth of psychiatry. The review process emphasizes scientific soundness over novelty. This makes it suitable for pilot studies, replication work, and research from smaller centers. The review timeline can be unpredictable, so submit with patience.
Journal of Clinical Psychiatry
JCP targets practicing psychiatrists and publishes clinical trials, practice guidelines, and treatment reviews. It's a solid choice for industry-sponsored trials and clinical pharmacology studies. The review process can be slow, but publications here are read by clinicians who prescribe.
Decision Framework: Matching Your Research
If your paper is a large RCT with clinical implications, Lancet Psychiatry or JAMA Psychiatry are the targets. AJP is a strong fallback.
If your paper involves neuroimaging or circuit neuroscience, Biological Psychiatry is the right fit. Molecular Psychiatry works for genetic and molecular approaches.
If your paper is epidemiological or population-based, Psychological Medicine, JAMA Psychiatry, or Acta Psychiatrica Scandinavica are all good options.
If your paper is about schizophrenia or psychosis, Schizophrenia Bulletin should be your first subspecialty choice.
If your paper needs open access, Translational Psychiatry offers Nature group branding. BJPsych Open and Frontiers in Psychiatry are more accessible.
If your paper is qualitative or mixed-methods, consider Psychological Medicine or BJPsych. Pure qualitative work faces challenges at biologically oriented journals.
Common Mistakes in Psychiatry Journal Selection
Sending neuroimaging papers to clinical journals. AJP and JAMA Psychiatry occasionally publish imaging studies, but the focus must be clinically relevant. If your paper is about fMRI methodology or basic neuroscience, Biological Psychiatry or NeuroImage is more appropriate.
Ignoring the biological vs. clinical divide. Biological Psychiatry and Molecular Psychiatry want mechanisms. AJP and JAMA Psychiatry want clinical evidence. These are fundamentally different editorial philosophies.
Submitting qualitative research to quantitative journals. Most top-tier psychiatry journals have a strong quantitative bias. If your work is qualitative, choose journals that explicitly welcome mixed or qualitative methods.
Underestimating the value of subspecialty journals. Journals like Schizophrenia Bulletin, Journal of Affective Disorders, and Addiction carry real weight in their domains. A publication in Schizophrenia Bulletin often matters more for a psychosis researcher than a paper in a lower-tier generalist journal.
Not accounting for review timelines. Psychiatry journals vary enormously in review speed. Molecular Psychiatry can take months. Lancet Psychiatry is often fast. Plan your submission strategy accordingly.
Strengthen Your Submission
Psychiatry journals receive thousands of submissions annually, and small details determine whether your paper moves to review or gets desk-rejected. Use Manusights' AI review tool to check your manuscript for formatting inconsistencies, statistical reporting issues, and structural weaknesses before you submit. In a field this competitive, preparation matters as much as the science itself.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.